Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Jongmans who wrote (571)	2/15/1999 11:41:00 AM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1073

Martin: Agree with most you said. However, we're getting slightly off-topic here. Let's compromise and say that (1) it's certainly not a good reflection on management when they need to hit the "bottomless desperation" trail, and (2) that it can create some opportunities. I, personally, leave companies that are at that stage, if I've been unlucky enough to have been near them (ARIA, as you know). Some may I revisit. You're correct, the crummy environment is why some companies found themselves hitting bottomless financing instead of secondaries. However, I can't think of a single company that didn't miss their milestones on the way down to that humiliation. Let's hope that the "good science" companies can recover, but let's also stay on-topic and drop this portion of the thread? Rick